BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$3.67B |
| 2 |
S&P Global
SPGI
|
+$3.35B |
| 3 |
Tesla
TSLA
|
+$2.24B |
| 4 |
Microsoft
MSFT
|
+$1.42B |
| 5 |
JPMorgan Chase
JPM
|
+$1.39B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$4.51B |
| 2 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$3.67B |
| 3 |
Meta Platforms (Facebook)
META
|
+$2.03B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.49B |
| 5 |
CONE
CyrusOne Inc Common Stock
CONE
|
+$1.33B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.94% |
| 2 | Healthcare | 13.65% |
| 3 | Financials | 12.55% |
| 4 | Consumer Discretionary | 10.62% |
| 5 | Industrials | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3076
MediaAlpha
MAX
$781M
| $22.9M | ﹤0.01% |
1,381,306
-7,536
| -0.5% | -$105K |
|
3077
Amalgamated Financial
AMAL
$1.48B
| $22.8M | ﹤0.01% |
1,270,024
+27,955
| +2% | +$478K |
|
3078
Dyne Therapeutics
DYN
$4.71B
| $22.8M | ﹤0.01% |
2,364,981
-46,416
| -2% | -$395K |
|
|
NEUE
3079
DELISTED
NeueHealth
NEUE
| $22.8M | ﹤0.01% |
147,492
+114,220
| +343% | +$25.4M |
|
|
KALV
3080
DELISTED
KalVista Pharmaceuticals
KALV
| $22.8M | ﹤0.01% |
1,544,027
+39,407
| +3% | +$566K |
|
3081
Century Casinos
CNTY
$36.3M
| $22.7M | ﹤0.01% |
1,901,135
-12,643
| -0.7% | -$143K |
|
3082
Blue Bird Corp
BLBD
$2.36B
| $22.7M | ﹤0.01% |
1,204,245
+92,140
| +8% | +$1.68M |
|
|
SVNAU
3083
DELISTED
7 Acquisition Corp Unit
SVNAU
| $22.6M | ﹤0.01% |
2,254,000
| – | – |
|
3084
Aurinia Pharmaceuticals
AUPH
$1.87B
| $22.6M | ﹤0.01% |
1,827,416
+6,677
| +0.4% | +$103K |
|
3085
Genius Sports
GENI
$1.89B
| $22.6M | ﹤0.01% |
4,910,973
-381,140
| -7% | -$2.19M |
|
3086
iShares MSCI Intl Momentum Factor ETF
IMTM
$4.17B
| $22.4M | ﹤0.01% |
631,174
-277,419
| -31% | -$9.87M |
|
|
YELL
3087
DELISTED
Yellow Corporation Common Stock
YELL
| $22.3M | ﹤0.01% |
3,185,197
-55,127
| -2% | -$526K |
|
3088
Allient
ALNT
$1.53B
| $22.3M | ﹤0.01% |
747,804
-9,515
| -1% | -$333K |
|
3089
Agnico Eagle Mines
AEM
$74.6B
| $22.3M | ﹤0.01% |
364,215
+111,208
| +44% | +$6.02M |
|
3090
Playboy Inc
PLBY
$136M
| $22.3M | ﹤0.01% |
1,703,156
+57,863
| +4% | +$974K |
|
|
BRT
3091
BRT Apartments
BRT
$282M
| $22.2M | ﹤0.01% |
928,235
-18,433
| -2% | -$414K |
|
3092
Standard BioTools
LAB
$339M
| $22.1M | ﹤0.01% |
6,165,716
-85,514
| -1% | -$295K |
|
|
IAS
3093
DELISTED
Integral Ad Science
IAS
| $22.1M | ﹤0.01% |
1,603,564
+513,654
| +47% | +$8.75M |
|
3094
iShares Core MSCI Europe ETF
IEUR
$9B
| $22.1M | ﹤0.01% |
414,120
+74,207
| +22% | +$4.06M |
|
3095
Miller Industries
MLR
$572M
| $22M | ﹤0.01% |
780,877
-36,578
| -4% | -$1.13M |
|
|
VBIV
3096
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $21.9M | ﹤0.01% |
440,704
-1,603
| -0.4% | -$79.2K |
|
3097
Lifecore Biomedical
LFCR
$165M
| $21.9M | ﹤0.01% |
1,892,678
-53,780
| -3% | -$599K |
|
3098
Aegon
AEG
$14B
| $21.9M | ﹤0.01% |
4,331,539
-80,573
| -2% | -$407K |
|
3099
Kodak
KODK
$828M
| $21.9M | ﹤0.01% |
3,345,766
-9,766
| -0.3% | -$46.4K |
|
3100
Cognyte Software
CGNT
$676M
| $21.8M | ﹤0.01% |
1,928,157
+87,059
| +5% | +$1.01M |
|
Similar funds
BlackRock's Q1 2022 Portfolio in Review
As of Q1 2022, BlackRock held 6,014 positions worth $3.71T, down 5.5% from $3.93T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
BlackRock's Q1 2022 filing shows 170 new, 2,466 increased, 2,626 reduced and 167 closed positions. Its largest new stake was Constellation Energy: 21,495,337 shares worth $1.21B. The largest sale was Xilinx Inc, an estimated $4.51B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q1 2022 buy was Constellation Energy: 21,495,337 shares worth $1.21B.
- BlackRock added most to Advanced Micro Devices in Q1 2022, an estimated $3.67B increase.
- BlackRock's biggest Q1 2022 reduction was Meta Platforms (Facebook), cutting an estimated $2.03B.
- BlackRock fully exited Xilinx Inc in Q1 2022, selling an estimated $4.51B.
- BlackRock's ten largest holdings make up 21% of its $3.71T portfolio in Q1 2022.
- BlackRock opened 170 new positions and closed 167 in Q1 2022.
- BlackRock's portfolio value fell 5.5% quarter-over-quarter to $3.71T.
Based on BlackRock's 13F filing for Q1 2022, filed 12 May 2022.